Tertia Dex

Tertia has over 20 years' experience in the biopharmaceutical development and manufacturing industry with more than half that time spent in contract development and manufacturing organisations (CDMO) leadership roles . With exposure to over 100 different biological products, she is an expert in CMC and program management with a track record of delivering CMC programs aligned with company strategic needs.

Having worked most recently as Director of Program Management & Business Management at Patheon Biologics (part of Thermo Fisher Scientific, formerly DSM Biologics), she is a proven leader with demonstrated success in delivering clinical and commercial programs across multiple therapeutic areas. Her responsibilities included oversight of the Program Management and project teams to deliver all customer programs, business management, contract & financial management, greenfield facility establishment, business development, regulatory strategy and operational excellence initiatives including global project leadership involving multi-divisionary teams.

Prior to joining DSM/Patheon, she held numerous leadership and technical roles in process & analytical development, technology transfer, scale-up and cGMP manufacture, bioprocess management, validation, and commercialisation within both product development companies and CDMOs, including Lonza, UK.

Tertia holds a Bachelor of Biotechnology with First Class Honours at Griffith University, Qld, Australia.